+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Spinal Muscular Atrophy Market and Competitive Landscape - 2020

  • ID: 5023440
  • Report
  • April 2020
  • Region: Europe
  • Fore Pharma
1 of 2
The research report Europe Spinal Muscular Atrophy Market and Competitive Landscape - 2020, provides comprehensive insights into the Spinal Muscular Atrophy pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecasts the Spinal Muscular Atrophy market size and drug sales. It also provides insights into Spinal Muscular Atrophy epidemiology and late stage pipeline.

This research covers the following: Spinal Muscular Atrophy treatment options, Spinal Muscular Atrophy late stage clinical trials pipeline, Spinal Muscular Atrophy prevalence by countries, Spinal Muscular Atrophy market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries Germany, France, Italy, Spain, UK, Europe (EU5 Countries).

Research Scope:
  • Countries: Germany, France, Italy, Spain, UK, Europe
  • Spinal Muscular Atrophy pipeline: Find out drugs in clinical trials for the treatment of Spinal Muscular Atrophy by development phase 3, phase 2, and phase 1, by pharmacological class and company
  • Spinal Muscular Atrophy epidemiology: Find out the number of patients diagnosed (prevalence) with Spinal Muscular Atrophy by countries
  • Spinal Muscular Atrophy drugs: Identify key drugs marketed and prescribed for Spinal Muscular Atrophy in the US, including trade name, molecule name, and company
  • Spinal Muscular Atrophy drugs sales: Find out the sales value for Spinal Muscular Atrophy drugs by countries
  • Spinal Muscular Atrophy market valuations: Find out the market size for Spinal Muscular Atrophy drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2024
  • Spinal Muscular Atrophy drugs market share: Find out the market shares for key drugs by countries
Benefits of this Research:
  • Evaluate commercial market opportunities for Spinal Muscular Atrophy drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in the Spinal Muscular Atrophy market
  • Develop in-depth knowledge of competition and markets
  • Analyze Spinal Muscular Atrophy drug sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track Market Events and Trends and analyze key events in the Spinal Muscular Atrophy market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies
Note: Product cover images may vary from those shown
2 of 2
1. Spinal Muscular Atrophy Treatment Options

2. Spinal Muscular Atrophy Pipeline Insights
2.1. Spinal Muscular Atrophy Phase 3 Clinical Trials
2.2. Spinal Muscular Atrophy Phase 2 Clinical Trials
2.3. Spinal Muscular Atrophy Phase 1 Clinical Trials

3. Spinal Muscular Atrophy Epidemiology Analysis by Countries

4. Germany Spinal Muscular Atrophy Market Insights
4.1. Marketed Drugs for Spinal Muscular Atrophy in Germany
4.2. Germany Spinal Muscular Atrophy Market Size & Forecast
4.3. Germany Spinal Muscular Atrophy Drugs Sales Forecast
4.4. Germany Spinal Muscular Atrophy Market Share Analysis

5. France Spinal Muscular Atrophy Market Insights
5.1. Marketed Drugs for Spinal Muscular Atrophy in France
5.2. France Spinal Muscular Atrophy Market Size & Forecast
5.3. France Spinal Muscular Atrophy Product Sales Forecast
5.4. France Spinal Muscular Atrophy Market Share Analysis

6. Italy Spinal Muscular Atrophy Market Insights
6.1. Marketed Drugs for Spinal Muscular Atrophy in Italy
6.2. Italy Spinal Muscular Atrophy Market Size & Forecast
6.3. Italy Spinal Muscular Atrophy Product Sales Forecast
6.4. Italy Spinal Muscular Atrophy Market Share Analysis

7. Spain Spinal Muscular Atrophy Market Insights
7.1. Marketed Drugs for Spinal Muscular Atrophy in Spain
7.2. Spain Spinal Muscular Atrophy Market Size & Forecast
7.3. Spain Spinal Muscular Atrophy Product Sales Forecast
7.4. Spain Spinal Muscular Atrophy Market Share Analysis

8. UK Spinal Muscular Atrophy Market Insights
8.1. Marketed Drugs for Spinal Muscular Atrophy in UK
8.2. UK Spinal Muscular Atrophy Market Size & Forecast
8.3. UK Spinal Muscular Atrophy Product Sales Forecast
8.4. UK Spinal Muscular Atrophy Market Share Analysis

9. Europe Spinal Muscular Atrophy Market Insights
9.1. Europe Spinal Muscular Atrophy Market Size & Forecast
9.2. Europe Spinal Muscular Atrophy Product Sales Forecast
9.3. Europe Spinal Muscular Atrophy Market Share Analysis

10. Research Methodology

List of Tables
Table 1: Spinal Muscular Atrophy Phase 3 Clinical Trials, Global, 2020
Table 2: Spinal Muscular Atrophy Phase 2 Clinical Trials, Global, 2020
Table 3: Spinal Muscular Atrophy Phase 1 Clinical Trials, Global, 2020
Table 4: Spinal Muscular Atrophy Prevalence by Countries, 2016 - 2024
Table 5: Marketed Drugs for Spinal Muscular Atrophy in Germany, 2019
Table 6: Germany Spinal Muscular Atrophy Market Size & Forecast ($mn), 2016 - 2024
Table 7: Germany Spinal Muscular Atrophy Product Sales ($mn), 2016 - 2024
Table 8: Germany Spinal Muscular Atrophy Market Events and Trends, 2016 - 2024
Table 9: Marketed Drugs for Spinal Muscular Atrophy in France, 2019
Table 10: France Spinal Muscular Atrophy Market Size & Forecast ($mn), 2016 - 2024
Table 11: France Spinal Muscular Atrophy Product Sales ($mn), 2016 - 2024
Table 12: France Spinal Muscular Atrophy Market Events and Trends, 2016 - 2024
Table 13: Marketed Drugs for Spinal Muscular Atrophy in Italy, 2019
Table 14: Italy Spinal Muscular Atrophy Market Size & Forecast ($mn), 2016 - 2024
Table 15: Italy Spinal Muscular Atrophy Product Sales ($mn), 2016 - 2024
Table 16: Italy Spinal Muscular Atrophy Market Events and Trends, 2016 - 2024
Table 17: Marketed Drugs for Spinal Muscular Atrophy in Spain, 2019
Table 18: Spain Spinal Muscular Atrophy Market Size & Forecast ($mn), 2016 - 2024
Table 19: Spain Spinal Muscular Atrophy Product Sales ($mn), 2016 - 2024
Table 20: Spain Spinal Muscular Atrophy Market Events and Trends, 2016 - 2024
Table 21: Marketed Drugs for Spinal Muscular Atrophy in UK, 2019
Table 22: UK Spinal Muscular Atrophy Market Size & Forecast ($mn), 2016 - 2024
Table 23: UK Spinal Muscular Atrophy Product Sales ($mn), 2016 - 2024
Table 24: UK Spinal Muscular Atrophy Market Events and Trends, 2016 - 2024
Table 25: Europe Spinal Muscular Atrophy Market Size & Forecast ($mn), 2016 - 2024
Table 26: Europe Spinal Muscular Atrophy Product Sales ($mn), 2016 - 2024

List of Figures
Figure 1: Spinal Muscular Atrophy Pipeline by Phase (%), Global, 2020
Figure 2: Spinal Muscular Atrophy Prevalence by Countries, 2016 - 2024
Figure 3: Germany Spinal Muscular Atrophy Market Size ($mn), 2016 - 2024
Figure 4: Germany Spinal Muscular Atrophy Product Sales ($mn), 2016 - 2024
Figure 5: Germany Spinal Muscular Atrophy Market Share by Drugs (%), 2019
Figure 6: Germany Spinal Muscular Atrophy Market - Future Market Share (%), 2024
Figure 7: France Spinal Muscular Atrophy Market Size ($mn), 2016 - 2024
Figure 8: France Spinal Muscular Atrophy Product Sales ($mn), 2016 - 2024
Figure 9: France Spinal Muscular Atrophy Market Share by Drugs (%), 2019
Figure 10: France Spinal Muscular Atrophy Market - Future Market Share (%), 2024
Figure 11: Italy Spinal Muscular Atrophy Market Size ($mn), 2016 - 2024
Figure 12: Italy Spinal Muscular Atrophy Product Sales ($mn), 2016 - 2024
Figure 13: Italy Spinal Muscular Atrophy Market Share by Drugs (%), 2019
Figure 14: Italy Spinal Muscular Atrophy Market - Future Market Share (%), 2024
Figure 15: Spain Spinal Muscular Atrophy Market Size ($mn), 2016 - 2024
Figure 16: Spain Spinal Muscular Atrophy Product Sales ($mn), 2016 - 2024
Figure 17: Spain Spinal Muscular Atrophy Market Share by Drugs (%), 2019
Figure 18: Spain Spinal Muscular Atrophy Market - Future Market Share (%), 2024
Figure 19: UK Spinal Muscular Atrophy Market Size ($mn), 2016 - 2024
Figure 20: UK Spinal Muscular Atrophy Product Sales ($mn), 2016 - 2024
Figure 21: UK Spinal Muscular Atrophy Market Share by Drugs (%), 2019
Figure 22: UK Spinal Muscular Atrophy Market - Future Market Share (%), 2024
Figure 23: Europe Spinal Muscular Atrophy Market Size ($mn), 2016 - 2024
Figure 24: Europe Spinal Muscular Atrophy Product Sales ($mn), 2016 - 2024
Figure 25: Europe Spinal Muscular Atrophy Market Share by Drugs (%), 2019
Figure 26: Europe Spinal Muscular Atrophy Market - Future Market Share (%), 2024
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll